SAM
JAZZ icon

Storebrand Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Storebrand Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3M Buy
109,183
+49
+0% +$10.7K 0.06% 257
2026
Q1 		$20.6M Hold
109,134
– – 0.06% 277
2025
Q4 		$18.6M Sell
109,134
-1,313
-1% -$201K 0.05% 292
2025
Q3 		$14.6M Buy
110,447
+33,000
+43% +$3.96M 0.04% 333
2025
Q2 		$8.22M Buy
77,447
+28,299
+58% +$3.07M 0.02% 424
2025
Q1 		$6.1M Sell
49,148
-17,917
-27% -$2.34M 0.02% 463
2024
Q4 		$8.26M Sell
67,065
-23,838
-26% -$2.81M 0.03% 423
2024
Q3 		$10.1M Sell
90,903
-1,074
-1% -$118K 0.03% 388
2024
Q2 		$9.82M Buy
91,977
+18,611
+25% +$2.05M 0.03% 386
2024
Q1 		$8.83M Buy
73,366
+403
+0.6% +$49.4K 0.03% 408
2023
Q4 		$8.97M Buy
72,963
+4,598
+7% +$574K 0.03% 405
2023
Q3 		$8.85M Sell
68,365
-324
-0.5% -$43.2K 0.04% 379
2023
Q2 		$8.52M Buy
68,689
+3,643
+6% +$490K 0.04% 400
2023
Q1 		$9.52M Buy
65,046
+3,001
+5% +$444K 0.05% 373
2022
Q4 		$9.88M Buy
62,045
+5,889
+10% +$863K 0.05% 350
2022
Q3 		$7.49M Sell
56,156
-46,610
-45% -$7.09M 0.05% 381
2022
Q2 		$16M Buy
102,766
+5,449
+6% +$839K 0.09% 260
2022
Q1 		$15.1M Sell
97,317
-415
-0.4% -$60.2K 0.07% 293
2021
Q4 		$12.5M Sell
97,732
-6,649
-6% -$874K 0.06% 344
2021
Q3 		$13.6M Sell
104,381
-7,208
-6% -$1.09M 0.07% 319
2021
Q2 		$19.8M Buy
111,589
+85,248
+324% +$14.8M 0.1% 258
2021
Q1 		$4.33M Hold
26,341
– – 0.02% 534
2020
Q4 		$4.35M Sell
26,341
-1,536
-6% -$229K 0.03% 513
2020
Q3 		$3.97M Sell
27,877
-7,677
-22% -$952K 0.03% 478
2020
Q2 		$3.92M Sell
35,554
-70,042
-66% -$7.75M 0.03% 451
2020
Q1 		$10.5M Buy
+105,596
New +$13.7M 0.11% 208

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Storebrand Asset Management's JAZZ Position: Q2 2026 in Review

Storebrand Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 0.04% in Q2 2026, buying an estimated $10.7K and bringing the position to 109,183 shares worth $26.3M. The position accounts for 0.06% of the portfolio, ranked #257.

Storebrand Asset Management first reported a position in JAZZ in Q1 2020 and has held it in 26 quarters since. 602 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Storebrand Asset Management held 109,183 shares of Jazz Pharmaceuticals worth $26.3M as of Q2 2026.
  • Storebrand Asset Management bought 49 Jazz Pharmaceuticals shares in Q2 2026, an estimated $10.7K.
  • Jazz Pharmaceuticals made up 0.06% of Storebrand Asset Management's portfolio in Q2 2026, its #257 holding.
  • Storebrand Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • 602 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Storebrand Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.